about
Inherited metabolic disease in companion animals: searching for nature's mistakesMucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyEngineering large animal models of human diseaseBiomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff diseaseHigh resolution MRI anatomy of the cat brain at 3 Tesla.Development and use of DNA archives at veterinary teaching hospitals to investigate the genetic basis of disease in dogsTranslational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogsIgE-based immunotherapy of cancer: challenges and chances.Development of a gene transfer-based treatment for radiation-induced salivary hypofunctionCharacterisation of the circulating acellular proteome of healthy sheep using LC-MS/MS-based proteomics analysis of serum.Gene therapy in large animal models of human genetic diseases. IntroductionMutation discovered in a feline model of human congenital retinal blinding disease.AAV5-mediated gene transfer to the parotid glands of non-human primatesHuman parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer.Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapyA genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivoProtein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs.Gene delivery in salivary glands: from the bench to the clinicGene therapy for the nervous system: challenges and new strategies.Beyond the mouse monopoly: studying the male germ line in domestic animal models.X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.Haemophilia A: molecular insights.In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions.Quantitative assessment of the canine pupillary light reflexCyclic Helix B Peptide in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia-Reperfusion Injury in Isolated Porcine Kidneys.Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectorsExosomal RNA as biomarkers and the therapeutic potential of exosome vectors.IL-12 based gene therapy in veterinary medicine.Spinal hyperostosis in humans and companion animals.Animal models for metabolic, neuromuscular and ophthalmological rare diseases.Molecular cues for development and regeneration of salivary glands.Gene therapy for the neurological manifestations in lysosomal storage disorders.Naturally occurring spinal hyperostosis in dogs as a model for human spinal disorders.Stem cells and regenerative medicine in domestic and companion animals: a multispecies perspective.Equine performance genes and the future of doping in horseracing.Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2.Ex vivo fluorescence molecular tomography of the spine.
P2860
Q24595262-2F23E36D-72D7-40DC-BEC2-57528A4643F6Q24651989-66D1F77A-77F3-4AED-B124-2B03AF93AC14Q26785547-4C27A2B9-8823-445B-93C7-44687BDF1F3BQ30394711-E1DE627F-2B8A-4274-B51C-613EF5CB4DBDQ30413378-24950D7A-623A-4896-9E70-5FF6C8DB8F0BQ30856794-C765791B-21EF-4247-A884-1E7E97C11A5BQ30891500-09D2109D-0EF4-4938-A728-9C3DF2494E66Q33619979-418B1702-3504-4613-B1D8-CDEBEBE28268Q33637630-9EC296F2-0020-40AD-9D06-9FECDA1B11BCQ33784953-D3F476C4-A940-48FA-AA1E-50BAFB4470B1Q33808511-E9792D8D-71D3-45B9-AD57-CBDC1DFB6611Q33938150-8EB041CC-16FB-4849-A541-D5F8D1561C1AQ34470293-6B81A9D2-705C-486E-B663-FAB8D9D2776AQ34511805-4E89BD0F-9E88-4CF1-82AC-ECD089A9BE12Q34925284-B1BBB46C-CCA9-458B-8E9D-3C9A63A62931Q35005484-8F6804FD-A998-4BC4-800C-9A028941B86FQ35006603-FBCB6731-27CB-4C98-960E-298CE6B6DE44Q35174932-1068DE39-6204-49A8-B801-46ECC021EC42Q35255990-B129A48F-483D-4B4F-8006-50B8F487D59DQ35340196-6A0A9C76-BBB6-4F1D-B58E-4B6C22C16E56Q35974786-8A885D46-4760-4FAB-939C-5E7355B24606Q36222337-46A6F4E1-AC43-4647-8D8D-FD69661D5D85Q36793856-E268FCE6-6AB0-48AF-AF6F-F2E625B65A58Q37056724-E739F325-B666-47BD-AF92-9B09FCC56A67Q37095330-BF4CF4FC-3ED4-4DFB-B696-F2D413FDAB0CQ37097716-BF59CB3A-6195-4F6B-B1A9-801304D873AFQ37601170-9B2AD1A5-A111-4C2F-B246-EF7484D23FD2Q38002919-362DD2A6-A8FC-4FC8-8575-ECCFAFF59336Q38061510-456F6DF5-8BC8-4076-BEF6-4E99B7ADFEE8Q38082551-7B733078-A32D-471A-BEBD-F6D3429B0E79Q38089518-D388ECE0-8FAD-45A9-9F17-502ED98E8FA0Q38159936-2A8E5754-7404-4BEA-836F-84C4443D6342Q38200599-4E13A8C4-4E58-4E2E-B4FC-7993DCEF38C0Q38220807-B9265F7B-6B45-482E-B761-DC0C05372561Q38256217-C3CB9FA5-D414-4287-ACB8-547DFCCDD5ACQ38738678-EF366E50-DBC3-49AE-B72D-C23B8024F73CQ40093113-2FBFC70D-FAA0-45AC-912D-87889C9B3B51Q40319080-52711778-C607-4BA4-B687-356B4CD37A28Q41197893-7E589DD0-81D7-44B1-85C6-9E432BAD6A34Q41662723-A8678CAA-FDA2-46E0-BB8A-62A48D4A2686
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Large animal models and gene therapy.
@ast
Large animal models and gene therapy.
@en
type
label
Large animal models and gene therapy.
@ast
Large animal models and gene therapy.
@en
prefLabel
Large animal models and gene therapy.
@ast
Large animal models and gene therapy.
@en
P2860
P356
P1476
Large animal models and gene therapy.
@en
P2093
Margret Casal
Mark Haskins
P2860
P2888
P304
P356
10.1038/SJ.EJHG.5201535
P577
2006-03-01T00:00:00Z